Second, like SCLC tumor cells, CRAD tumor cells may secrete serum NSE, which correlates with tumor mass extension (Carney et al., 1982), therefore higher level of serum NSE may indicate aggravated tumor burden of the patients. The gene discussed is ENO2; the disease is small cell lung carcinoma.